1. Home
  2. IBG vs ARTL Comparison

IBG vs ARTL Comparison

Compare IBG & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBG
  • ARTL
  • Stock Information
  • Founded
  • IBG 2018
  • ARTL 2011
  • Country
  • IBG Australia
  • ARTL United States
  • Employees
  • IBG N/A
  • ARTL N/A
  • Industry
  • IBG Beverages (Production/Distribution)
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBG Consumer Staples
  • ARTL Health Care
  • Exchange
  • IBG Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • IBG 5.4M
  • ARTL 3.1M
  • IPO Year
  • IBG 2024
  • ARTL N/A
  • Fundamental
  • Price
  • IBG $0.57
  • ARTL $9.35
  • Analyst Decision
  • IBG Strong Buy
  • ARTL Strong Buy
  • Analyst Count
  • IBG 1
  • ARTL 2
  • Target Price
  • IBG N/A
  • ARTL $24.00
  • AVG Volume (30 Days)
  • IBG 529.3K
  • ARTL 124.2K
  • Earning Date
  • IBG 08-26-2025
  • ARTL 08-13-2025
  • Dividend Yield
  • IBG N/A
  • ARTL N/A
  • EPS Growth
  • IBG N/A
  • ARTL N/A
  • EPS
  • IBG N/A
  • ARTL N/A
  • Revenue
  • IBG $2,931,243.00
  • ARTL N/A
  • Revenue This Year
  • IBG N/A
  • ARTL N/A
  • Revenue Next Year
  • IBG N/A
  • ARTL N/A
  • P/E Ratio
  • IBG N/A
  • ARTL N/A
  • Revenue Growth
  • IBG N/A
  • ARTL N/A
  • 52 Week Low
  • IBG $0.44
  • ARTL $4.92
  • 52 Week High
  • IBG $3.35
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • IBG 41.82
  • ARTL 41.84
  • Support Level
  • IBG $0.54
  • ARTL $9.16
  • Resistance Level
  • IBG $0.72
  • ARTL $10.55
  • Average True Range (ATR)
  • IBG 0.07
  • ARTL 0.76
  • MACD
  • IBG -0.01
  • ARTL -0.04
  • Stochastic Oscillator
  • IBG 10.71
  • ARTL 48.94

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: